A research approach to diagnosing prostate cancer uses sound waves to extract "bubbles of information" from cells[1]. Transrectal ultrasound (TRUS) uses sound waves to create images of the prostate and is often used to guide biopsies[1][2][4]. Multiparametric MRI of the prostate identifies suspicious areas and assesses cancer spread using the PIRADS score[1]. In the first-ever clinical trial, they are testing a treatment strategy combining imaging and high-frequency sound waves to destroy prostate tumors[3]. This method has fewer side effects, short treatment and patients return to activities after two weeks[3]. In Slovakia, they are testing ultrasound therapy without a scalpel, which targets only the tumor, with a temperature of up to 85 °C and high acoustic pressure to destroy cells[6]. Patients return home on the second or third day without typical consequences such as incontinence or loss of erectile function[6].